You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

Article metrics

Article menu

Download PDFPDF

Inflammatory arthritis
Original research
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

 

Online download statistics by month:

Online download statistics by month: February 2023 to August 2024

AbstractFullPdf
Feb 2023398539731416
Mar 2023279127601146
Apr 202316281582703
May 202316711632877
Jun 202315061468531
Jul 202311741146366
Aug 2023870835358
Sep 2023837789340
Oct 2023888815341
Nov 2023904828361
Dec 2023797724336
Jan 2024810672353
Feb 202412451221378
Mar 2024796741416
Apr 2024899849416
May 2024764736411
Jun 2024645611277
Jul 2024614576294
Aug 2024509480239
Total23333224389559